Key Moments
#21 – Tom Dayspring, M.D., FACP, FNLA – Part II of V: Lipid metrics and cholesterol regulation
Key Moments
Lipidology 101: Understanding lipoproteins, cholesterol metrics, and their role in health.
Key Insights
Lipids circulate in the body via lipoproteins, which are structures composed of lipids and proteins.
Lipoprotein density is determined by the ratio of lipid to protein content, influencing their function and role in disease.
Standard cholesterol tests (LDL-C, HDL-C, Triglycerides) are indirect measures and can be less informative than particle number (LDL-P) or ApoB.
ApoB is a reliable marker for the number of atherogenic particles (LDL and VLDL), which is a key driver of atherosclerosis.
Sterols, including cholesterol, are essential for cell membranes and hormone production, with tight regulation of synthesis and transport.
Phytosterols, plant-derived sterols, are not well absorbed by the human body and can interfere with cholesterol absorption, but their use requires caution due to potential adverse effects.
THE FUNDAMENTALS OF LIPIDS AND LIPOPROTEINS
Lipids, being hydrophobic, require specialized transport vehicles in the aqueous environment of blood plasma. These vehicles are lipoproteins, spherical structures with a core of lipids (like triglycerides and cholesterol esters) and an outer shell of phospholipids, free cholesterol, and apolipoproteins. Apolipoproteins not only provide structural integrity but also act as ligands for cellular receptors, dictating the lipoprotein's fate. Early research, notably by John Gofman, utilized ultracentrifugation to separate these particles based on their density, revealing different types.
DIFFERENTIATING LIPOPROTEIN DENSITIES AND STRUCTURES
The density of a lipoprotein is primarily determined by its lipid-to-protein ratio; higher lipid content results in lower density and greater buoyancy. Broad categories include chylomicrons, VLDL, IDL, LDL, and HDL. While chylomicrons and VLDL/LDL/IDL originate from different lineages and generally decrease in size as they lose lipids, HDL particles are formed differently. A key apolipoprotein, ApoB, is a structural component found on VLDL, IDL, and LDL, and its presence is crucial for their interaction with receptors like the LDL receptor.
EVOLUTION OF CHOLESTEROL MEASUREMENT AND METRICS
Historically, only total cholesterol could be measured. Later, HDL cholesterol and triglycerides became measurable. LDL cholesterol was initially estimated using a formula (Friedewald equation), which involved subtracting HDL and triglyceride contributions from total cholesterol. While useful, this calculation falters with high triglyceride levels. Newer direct LDL-C assays and more importantly, ApoB or LDL particle number (LDL-P) measured by methods like NMR, offer a more direct assessment of atherogenic particle concentration, which is a superior predictor of cardiovascular risk.
ATHEROGENIC PARTICLES AND CARDIOVASCULAR RISK
The scientific consensus is shifting towards understanding that the number of atherogenic particles, particularly LDL particles, is a more critical determinant of cardiovascular risk than the amount of cholesterol within those particles. These particles can infiltrate the arterial wall, initiating inflammatory processes that lead to plaque formation. ApoB is present on every atherogenic particle (VLDL, IDL, LDL), making it a proxy for their total number. High ApoB or LDL-P levels indicate a greater risk, even if LDL-C levels appear normal.
BIOLOGY OF STEROLS: CHOLESTEROL, STANOLS, AND PLANT STEROLS
Sterols, including cholesterol, are vital for cell membranes and hormone synthesis. Cholesterol itself has a specific structure. Sterols are tightly regulated through synthesis and transport (influx/efflux). Stanols are saturated sterols that are poorly absorbed and can help lower cholesterol absorption. Plant sterols (phytosterols) are structurally similar to cholesterol but are even less absorbed. While they can compete with cholesterol absorption, their long-term use and potential accumulation in the body warrant caution, as evolution appears to have designed mechanisms to limit their absorption.
CHOLESTEROL HOMEOSTASIS AND TRANSPORT PATHWAYS
Cholesterol homeostasis involves a complex interplay of synthesis, absorption, and transport. Every cell can synthesize cholesterol, but certain tissues, like the adrenal glands, may increase their cellular uptake during periods of high demand for steroid hormones. Reverse cholesterol transport, the process of moving cholesterol from peripheral tissues back to the liver for excretion or to the intestine, is crucial. While HDL plays a role (direct reverse cholesterol transport), the trans-intestinal cholesterol efflux (TICE) pathway, where cholesterol is directly transferred from the enterocyte to the gut lumen, is also a significant mechanism for cholesterol removal.
REGULATION OF CHOLESTEROL SYNTHESIS AND CELLULAR NEEDS
Cholesterol is synthesized through a complex pathway involving numerous enzymatic steps, starting from acetyl-CoA. While the body has sophisticated mechanisms to regulate cholesterol synthesis, influx, and efflux to maintain cellular homeostasis, interventions like statins primarily target synthesis. It's important to note that plasma lipid measurements are snapshots and do not fully capture the dynamic flux of cholesterol within cells or tissues, nor do they reflect localized cholesterol pools, such as those in the brain, which has its own independent cholesterol metabolism.
Mentioned in This Episode
●Supplements
●Software & Apps
●Companies
●Organizations
●Drugs & Medications
●Concepts
●People Referenced
Common Questions
Lipoproteins are water-soluble transportation vehicles made of proteins and lipids. They are essential because lipids, being hydrophobic, cannot circulate freely in the plasma. Atherosclerosis, a major lipid-associated disease, occurs when lipoproteins deliver sterols inappropriately, such as to arterial walls.
Topics
Mentioned in this video
A large, structural, non-transferable apolipoprotein found on VLDL, IDL, and LDL particles. It serves as a ligand for LDL receptors and is a key indicator of LDL particle concentration and cardiovascular risk.
A protein transporter in the brain for lipids, distinct from ApoE in peripheral lipoproteins. It attaches to cholesterol and other sterols for transport within the central nervous system.
A metabolic state where the body uses fat as its primary energy source, which is seen as a beneficial adaptation during fasting, sparing muscle and hormones from being catabolized.
A steroid hormone produced by the adrenal cortex. Cholesterol is a precursor for cortisol synthesis, and during physiological stress, cells may increase cholesterol production and uptake for increased hormone output.
An intermediate molecule in the synthesis of cholesterol, formed when the linear precursor squalene bends into a ring structure. It is a key point in one of the two main cholesterol synthesis pathways.
A broad category of organic compounds with a specific four-ring structure. Cholesterol is a key sterol in humans, while stanols and phytosterols are related compounds with different absorption and functional properties.
The amount of cholesterol contained within high-density lipoprotein particles. Framingham studies showed low HDL and high triglycerides were more predictive of heart attack than high LDL.
A type of fat molecule. High triglycerides, along with low HDL cholesterol, were found to be highly predictive of myocardial infarction in the Framingham study.
A reproductive hormone. Cholesterol serves as a precursor for the synthesis of testosterone in certain cells.
A major pathway for cholesterol elimination where lipoproteins or other carriers bring cholesterol directly to the small intestine, and it is then excreted in stool, bypassing the liver.
A reproductive hormone. Cholesterol serves as a precursor for the synthesis of estrogen in certain cells.
A two-carbon molecule that serves as the starting point for cholesterol synthesis in cells. It undergoes a multi-step process to grow and form the complex structure of cholesterol.
A measurement of all cholesterol in the plasma, found within various lipoproteins. Historically, it was the first lipid metric measured and correlated with heart disease risk, but it's now considered a 'poor man's ApoB level'.
A precursor molecule in cholesterol synthesis, similar to cholesterol but with a double bond at carbon 24 in the tail. A deficiency in the enzyme that saturates this bond can lead to a severe genetic disorder.
A metric that counts the number of low-density lipoprotein particles in the blood, considered a more accurate predictor of cardiovascular risk than LDL cholesterol levels alone.
A calculated metric that represents the total cholesterol minus HDL cholesterol. It is considered a better correlate with ApoB or LDL particle concentration than LDL cholesterol alone.
The amount of cholesterol contained within low-density lipoprotein particles. While commonly reported, it's considered less informative than LDL particle number or ApoB for assessing cardiovascular risk.
A sterol molecule essential for cell membranes, hormone synthesis, and bile acid production. It has a four-ring structure with a tail. Free cholesterol is hydroxylated, while cholesterol ester is the storage form.
Saturated sterol compounds related to cholesterol. Unlike cholesterol, stanols cannot be readily absorbed by the intestine and are pooped out, making them a target for cholesterol-lowering strategies, though they can be toxic in some individuals.
Sterols found in plants, structurally similar to cholesterol but with variations in the tail or ring structure. They are poorly absorbed by humans and can compete with cholesterol absorption, but excessive intake can be toxic.
A formula used to estimate LDL cholesterol levels based on total cholesterol, HDL cholesterol, and triglycerides. It was developed in the 1970s but has limitations, especially with high triglycerides.
A technology used to analyze lipids and lipoproteins by measuring spectral signals. It can provide various lipoprotein metrics, including particle numbers and cholesterol content, and is more advanced than basic assays.
A protein in the blood that can carry hormones, cholesterol, and phospholipids, playing a role in osmotic pressure and serving as a general carrier.
A protein in the proximal intestine that recognizes sterols. It binds most tightly to cholesterol, less so to phytosterols, and minimally to stanols, influencing their absorption into enterocytes.
A family of membrane transport proteins. Specifically, ABCG5 and ABCG8 form a heterodimer that acts as a gatekeeper, expelling sterols from enterocytes. They have different affinities, prioritizing phytosterols and stanols for excretion over cholesterol.
A severe metabolic response to infection, trauma, or sepsis. Patients experiencing SIRS often show a significant drop in HDL cholesterol, potentially due to increased hormone production requiring more cholesterol.
A disease characterized by the buildup of lipids and sterols in arterial walls, a process attributed to lipoproteins delivering these substances inappropriately.
An expert in lipid ology and associate editor for the Journal of Clinical Lipidology, featured in this discussion on lipoproteins, cholesterol, and sterols.
A physicist who discovered that lipids circulate in plasma within lipoproteins. He used ultracentrifugation to separate these particles based on density.
More from Peter Attia MD
View all 322 summaries
135 min381‒Alzheimer’s disease in women: how hormonal transitions impact the brain, new therapies, & more
9 minIs Industrial Processing the Real Problem With Seed Oils? | Layne Norton, Ph.D.
13 minCooking with Lard vs Seed Oils | Layne Norton, Ph.D.
146 min380 ‒ The seed oil debate: are they uniquely harmful relative to other dietary fats?
Found this useful? Build your knowledge library
Get AI-powered summaries of any YouTube video, podcast, or article in seconds. Save them to your personal pods and access them anytime.
Try Summify free